Within this study, additional questions could be addressed. For example, TNF in patients with diabetes is secreted mainly by the fat cells and is involved in the development of insulin resistance and decline in the pancreatic beta-cell function. Previous studies examined the effect of anti-TNF treatment on indices of insulin resistance in non-diabetic subjects and showed that chronic treatment with anti-TNF agents may improve insulin sensitivity in humans.